anemodeanin a has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Dai, X; Wang, B; Wang, W; Wu, B; Ye, L; Zhu, J | 1 |
| Chen, HZ; Fang, C; Gao, YG; Guan, YY; Liu, HJ; Liu, YR; Lu, Q; Luan, X; Xu, JR; Zhao, M | 1 |
2 other study(ies) available for anemodeanin a and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Topics: Animals; beta Catenin; Brain Neoplasms; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Mice; Neovascularization, Pathologic; Saponins; Vascular Endothelial Growth Factor A; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
Raddeanin A, a triterpenoid saponin isolated from Anemone raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling.
Topics: Anemone; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chick Embryo; Colorectal Neoplasms; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Neovascularization, Pathologic; Saponins; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish | 2015 |